217 related articles for article (PubMed ID: 27793328)
21. Reliable assessment of telomere maintenance mechanisms in neuroblastoma.
Meeser A; Bartenhagen C; Werr L; Hellmann AM; Kahlert Y; Hemstedt N; Nürnberg P; Altmüller J; Ackermann S; Hero B; Simon T; Peifer M; Fischer M; Rosswog C
Cell Biosci; 2022 Sep; 12(1):160. PubMed ID: 36153564
[TBL] [Abstract][Full Text] [Related]
22. Telomere maintenance is pivotal for high-risk neuroblastoma.
Hertwig F; Peifer M; Fischer M
Cell Cycle; 2016; 15(3):311-2. PubMed ID: 26653081
[No Abstract] [Full Text] [Related]
23. Telomerase activity, TERT expression, hTERT promoter alterations, and alternative lengthening of the telomeres (ALT) in meningiomas - a systematic review.
Stögbauer L; Stummer W; Senner V; Brokinkel B
Neurosurg Rev; 2020 Jun; 43(3):903-910. PubMed ID: 30788677
[TBL] [Abstract][Full Text] [Related]
24. Telomere length abnormalities and telomerase RNA component expression in gastroenteropancreatic neuroendocrine tumors.
Kim HS; Lee HS; Nam KH; Choi J; Kim WH
Anticancer Res; 2015 Jun; 35(6):3501-10. PubMed ID: 26026117
[TBL] [Abstract][Full Text] [Related]
25. Telomere Trimming and DNA Damage as Signatures of High Risk Neuroblastoma.
Yu EY; Cheung IY; Feng Y; Rabie MO; Roboz GJ; Guzman ML; Cheung NV; Lue NF
Neoplasia; 2019 Jul; 21(7):689-701. PubMed ID: 31128432
[TBL] [Abstract][Full Text] [Related]
26. Systematic analysis of telomere length and somatic alterations in 31 cancer types.
Barthel FP; Wei W; Tang M; Martinez-Ledesma E; Hu X; Amin SB; Akdemir KC; Seth S; Song X; Wang Q; Lichtenberg T; Hu J; Zhang J; Zheng S; Verhaak RG
Nat Genet; 2017 Mar; 49(3):349-357. PubMed ID: 28135248
[TBL] [Abstract][Full Text] [Related]
27. Telomerase reverse transcriptase expression protects transformed human cells against DNA-damaging agents, and increases tolerance to chromosomal instability.
Fleisig HB; Hukezalie KR; Thompson CA; Au-Yeung TT; Ludlow AT; Zhao CR; Wong JM
Oncogene; 2016 Jan; 35(2):218-27. PubMed ID: 25893297
[TBL] [Abstract][Full Text] [Related]
28. Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour?
Hiyama E; Hiyama K; Ohtsu K; Yamaoka H; Ichikawa T; Shay JW; Yokoyama T
Eur J Cancer; 1997 Oct; 33(12):1932-6. PubMed ID: 9516827
[TBL] [Abstract][Full Text] [Related]
29. Alternative lengthening of telomeres does exist in various canine sarcomas.
Kreilmeier T; Sampl S; Deloria AJ; Walter I; Reifinger M; Hauck M; Borst LB; Holzmann K; Kleiter M
Mol Carcinog; 2017 Mar; 56(3):923-935. PubMed ID: 27585244
[TBL] [Abstract][Full Text] [Related]
30. Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma.
Job S; Draskovic I; Burnichon N; Buffet A; Cros J; Lépine C; Venisse A; Robidel E; Verkarre V; Meatchi T; Sibony M; Amar L; Bertherat J; de Reyniès A; Londoño-Vallejo A; Favier J; Castro-Vega LJ; Gimenez-Roqueplo AP
Clin Cancer Res; 2019 Jan; 25(2):760-770. PubMed ID: 30301828
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic Targeting of
Huang M; Zeki J; Sumarsono N; Coles GL; Taylor JS; Danzer E; Bruzoni M; Hazard FK; Lacayo NJ; Sakamoto KM; Dunn JCY; Spunt SL; Chiu B
Cancer Res; 2020 Mar; 80(5):1024-1035. PubMed ID: 31900258
[TBL] [Abstract][Full Text] [Related]
32. Disease mutant analysis identifies a new function of DAXX in telomerase regulation and telomere maintenance.
Tang M; Li Y; Zhang Y; Chen Y; Huang W; Wang D; Zaug AJ; Liu D; Zhao Y; Cech TR; Ma W; Songyang Z
J Cell Sci; 2015 Jan; 128(2):331-41. PubMed ID: 25416818
[TBL] [Abstract][Full Text] [Related]
33. Translational practice of fluorescence in situ hybridisation to identify neuroblastic tumours with TERT rearrangements.
Yu Y; Zhang M; Yao X; Guan X; Jia C; Chu P; Zhang R; Yang Y; Jin Y; Wang H; Ni X; He L; Guo Y
J Pathol Clin Res; 2023 Nov; 9(6):475-487. PubMed ID: 37608330
[TBL] [Abstract][Full Text] [Related]
34. Thyroid carcinoma-featured telomerase activation and telomere maintenance: Biology and translational/clinical significance.
Yuan X; Yuan H; Zhang N; Liu T; Xu D
Clin Transl Med; 2022 Nov; 12(11):e1111. PubMed ID: 36394204
[TBL] [Abstract][Full Text] [Related]
35. Telomerase-dependent and independent telomere maintenance and its clinical implications in medullary thyroid carcinoma.
Wang N; Xu D; Sofiadis A; Höög A; Vukojević V; Bäckdahl M; Zedenius J; Larsson C
J Clin Endocrinol Metab; 2014 Aug; 99(8):E1571-9. PubMed ID: 24758186
[TBL] [Abstract][Full Text] [Related]
36. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
Jafri MA; Ansari SA; Alqahtani MH; Shay JW
Genome Med; 2016 Jun; 8(1):69. PubMed ID: 27323951
[TBL] [Abstract][Full Text] [Related]
37. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.
Yamaguchi H; Calado RT; Ly H; Kajigaya S; Baerlocher GM; Chanock SJ; Lansdorp PM; Young NS
N Engl J Med; 2005 Apr; 352(14):1413-24. PubMed ID: 15814878
[TBL] [Abstract][Full Text] [Related]
38. Telomere length is a prognostic factor in neuroblastoma.
Ohali A; Avigad S; Ash S; Goshen Y; Luria D; Feinmesser M; Zaizov R; Yaniv I
Cancer; 2006 Sep; 107(6):1391-9. PubMed ID: 16917952
[TBL] [Abstract][Full Text] [Related]
39. ALK Protein Expression Is Related to Neuroblastoma Aggressiveness But Is Not Independent Prognostic Factor.
Lee JW; Park SH; Kang HJ; Park KD; Shin HY; Ahn HS
Cancer Res Treat; 2018 Apr; 50(2):495-505. PubMed ID: 28546523
[TBL] [Abstract][Full Text] [Related]
40. Genome stability in Arabidopsis cells exhibiting alternative lengthening of telomeres.
Akimcheva S; Zellinger B; Riha K
Cytogenet Genome Res; 2008; 122(3-4):388-95. PubMed ID: 19188710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]